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Abstract
It is recognized that IDH mutation negative, low-grade epi-
lepsy associated tumors (LEAT) can show diffuse growth pat-
terns and lack the diagnostic hallmarks of either classical
dysembryoplastic neuroepithelial tumors (DNT) or typical gan-
glioglioma. “Nonspecific or diffuse DNT” and more recently
“polymorphous low-grade neuroepithelial tumor of the young” have
been terms used for these entities. There are few reports on the MRI
recognition of these diffuse glioneuronal tumors (dGNT), which is
important in planning the extent of surgical resection. In 27 LEATs
T1, T2, FLAIR, and postcontrast T1 MRI were evaluated and the pa-
thology reviewed, including immunostaining for NeuN, CD34,
MAP2, and IDH1. Each case was then independently classified by
pathology or MRI as simple DNT, complex DNT, or dGNT. There
was agreement in 23/27 (85%; Kappa score 0.62; p< 0.01). In 4
cases, there was discrepancy in the diagnosis of simple versus com-
plex DNT but 100% agreement achieved for dGNT. DNT showed
significantly more expansion of the cortex, cystic change and ventri-
cle extension than dGNT. dGNT showed significantly more subcor-
tical T2w hyperintensity and focal cortical atrophy which correlated
on pathology with CD34 expression, cortical neuronal loss and white
matter rarefaction. There was no distinct cortical dysplasia compo-
nent identified by MRI or pathology in any case. This study high-
lights that dGNT can be reliably discriminated on MRI from DNT.
Key Words: Dysembryoplastic neuroepithelial tumors (DNT),
Long-term epilepsy associated tumors, MRI.
INTRODUCTION
Dysembryoplastic neuroepithelial tumors (DNT) and
gangliogliomas are the most frequent types of long-term epi-
lepsy-associated tumors (LEATs) encountered in epilepsy
surgical series (1, 2). Common to both are their low-grade
behavior (equivalent to WHO grade I), mixed glioneuronal
composition and temporal lobe location, with epilepsy often
presenting in childhood to young adulthood (age range in large
series at diagnosis: 4–34 years in DNT (3) and 4–33 years in
ganglioglioma (4)) that is refractory to medical treatment.
DNT have been histologically divided into simple and com-
plex forms, both containing the pathognomonic specific glio-
neuronal element composed of oligodendrocyte-like cells
(OLC) but lacking the dysmorphic ganglion cell component of
gangliogliomas (5).
It has long been recognized, however, that a subset of
LEATs, representing up to 35% of cases in epilepsy tumor se-
ries (1), are difficult to classify microscopically, composed
primarily of OLC but showing diffuse, infiltrative, cortical
growth patterns, and lacking the specific criteria for either
DNT or ganglioglioma (6–11). Although their existence is rec-
ognized, they remain “controversial” in the recently revised
2016 WHO classification of CNS tumors (5) and the exact ter-
minology for these lesions in the spectrum of LEATs remains
undecided (2, 12). “Nonspecific DNT” (10), “diffuse DNT”
(6, 7, 11), “diffuse-oligodendroglial tumor” (13), and more re-
cently “polymorphous low-grade neuroepithelial tumor of the
young” (PLNTY) (14) are terms that have been used for what
is likely to be the same tumor group. Indeed, pathology
descriptions corroborate similar features: Widespread cortical
or hippocampal involvement beyond the main tumor mass,
CD34 expression and acquisition of degenerative and atrophic
changes, as rarefaction and cavitation of the white matter (1,
6, 7, 11, 14). Recent molecular genetic studies have also
shown high frequency of mutations in RAS–RAF–MAPK and
PI3K–AKT–mTOR pathways linking this group of tumors (2).
For this current study, for simplicity, we adopt the generic
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term “diffuse glioneuronal tumor” (dGNT) to encompass these
lesions. We do not propose this term dGNT as a new nomen-
clature for these tumors but merely as a “descriptor” to distin-
guish them from conventional DNT types for the purposes of
this study.
There are, however, few studies documenting the MRI
characteristics of dGNT. One study highlighted their poor-
delineation with grey-white matter blurring and subcortical
signal changes and “cortical dysplasia”-like features that con-
trasted to the cystic/nodular appearances of typical DNT (15).
Indeed, the widespread cortical infiltrative nature of dGNT
may have led to an overinterpretation of co-existing dysplasia
with these tumors (focal cortical dysplasia [FCD]-type IIIb
(16)), both by MRI and pathology, accounting for the wide
variation in its reporting over the years (6, 9, 17–21). There-
fore, improved MRI recognition of dGNT is paramount, both
for accurate pre-operative diagnosis and future surgical man-
agement when planning the extent of resection, in view of
their typically more extensive involvement (22).
The aim of this study was to retrospectively evaluate the
MRI features in a recently operated series of LEATs from an ep-
ilepsy surgical series to correlate this with histology features and
pathology diagnosis of tumor type. We aimed to identify MRI
criteria that could reliable discriminate dGNT from DNT as well
as assess the frequency of any co-exiting cortical dysplasia.
MATERIALS ANDMETHODS
Cases were selected retrospectively through the neuro-
pathology database at the National Hospital of Neurology and
Neurosurgery of adult patients who had undergone surgical
treatment for management of refractory epilepsy due to an
underlying low-grade tumor. The study has ethical ap-
proval through the UCL Epilepsy brain and tissue bank
(REC12SC0669). We included cases with a histological diag-
nosis of DNT or LEATs with diffuse growth patterns from
2008 to 2014 where there was consent for research and where
optimal pre-operative imaging was available for review. This
included availability of the following sequences acquired
with 1.5 T or 3 T MR scanners: Sagittal (T1, T2, FLAIR),
axial (T2, T2*, T1 post contrast, and DWI, 5 mm thickness),
coronal (T2 and FLAIR, 2 mm), and T1 MPR (multiplanar re-
construction) sagittal 1 mm reformatted in axial and coronal
plane. We did not include other glioma types in patients with-
out refractory epilepsy and we did not include series of typical
gangliogliomas or pediatric gliomas. This selection process
resulted in a final group of 27 cases available to study
(Table 1). In 19/27 cases interval pre-operative MRI images
were available to assess any tumor changes or progression.
Neuropathological Evaluation
The pathology macroscopic images and histology was
reviewed for each case by one neuropathologist (M.T.) on all
available histological slides including hematoxylin and eosin
(H&E), Luxol fast blue/cresyl violet, and available immuno-
histochemistry stains including NeuN, neurofilament (SMI32,
31), MAP2, synaptophysin, CD34, IDH1, Ki67 and molecular
pathology studies including 1p/19q analysis, BRAF fusion,
BRAF V600E mutation, and ATRX mutation (Supplementary
Data Table S1). All cases had been initially diagnosed (in 25/
27 cases by more than one other neuropathologist) as DNT,
diffuse DNT or mixed DNTþ ganglioglioma; there were no
changes to diagnosis following review. For each case, the
presence or not of 16 specific or defining as well as other his-
tological features (Supplementary Data Table S2) were
recorded. Confirmatory diagnosis of simple and complex
DNT was based on WHO criteria (5) and for dGNT on previ-
ously developed histological criteria for diffuse DNT (6): (i)
diffuse cortical infiltration pattern predominates, (ii) relative
lack of glioneuronal element, myxoid matrix, or nodular
growth pattern, (iii) underlying white matter often shows
rarefaction and cystic atrophy, (iv) tumor cytology is predomi-
nantly OLC, and (v) CD34 expression is often present in
lesion and perilesional cortex.
MRI Assessment
The MRI were then evaluated in a two-step process
blinded to the pathological diagnosis: First, the presence or ab-
sence of 25 specific features in each case was recorded. These
included location, size, shape, margins, cysts, calcification,
hemorrhage, enhancement pattern, bone remodeling, signal in-
tensity, peri-lesional signal change, contact with the ven-
tricles, multi-gyral involvement, cortical expansion, or
atrophy (Supplementary Data Table S2). Second, the cases
were then classified as one of 3 possible entities based on cur-
rent literature and the relative presence or absence of the
above features, for example, (i) simple DNT: Single well-
defined lesion, cystic components, and cortical expansion; (ii)
complex DNTs: Multicystic or “bubbly” appearances; (iii) dif-
fuse GNTs: Perilesional white matter signal changes and focal
cortical atrophy. Each case was categorized following a con-
sensus discussion and agreement between 3 neuroradiologists
on the imaging features (A.A., S.M., C.H.).
Correlation of MRI and Neuropathology
A comparison between the MRI derived diagnosis and
the neuropathological gold standard was performed and the
frequency of each of the MR features in each of the 3 tumor
entities was established. Statistical analysis using SPSS (IBM,
version 21; Spearman’s correlation, Kruskal–Wallis and
Mann–Whitney tests for nonparametric data) was carried out
to compare the level of agreement between radiological and
pathological diagnosis. Significant differences in the presence
of each radiological criteria between tumor groups were
assessed to evaluate the relative specificity of MRI features in
discriminating dGNT from DNT types. In addition, correlation
between MRI and pathology features was carried out.
RESULTS
Neuropathology and Molecular Genetics
The pathology review diagnosis confirmed simple DNT
in 6 cases, complex DNT in 8 cases, and dGNT in 13 cases
(Table 1). Molecular pathology in the dGNT confirmed that
none had an IDH1 mutation, and in 6 cases where ATRX
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mutation had been evaluated, this was not present. Ten cases
were investigated for 1p/19q chromosome LOH as part of the
routine work-up but this was not present in any. Analysis for
BRAF V600E mutation, however, was confirmed in 5/11
dGNT compared with 0/5 complex DNT and 0/3 simple DNT;
this included 1/3 cases of dGNT with focal aggregates of gan-
glion cells (see below).
MRI Agreement and Features
Twenty-two tumors were located in the temporal lobe, 2
in the frontal, 2 in the parietal and one in the occipital lobe
(Table 1). The MRI diagnosis was simple DNT in 6 cases,
complex DNT in 8 cases (Supplementary Data Fig. S1) and
dGNT (Fig. 1) in 13 cases. The MRI diagnosis was confirmed
neuropathologically in 85% (23/27) of cases (Kappa score
0.62; p< 0.000). There was 100% (13/13) agreement between
the MRI and neuropathological diagnosis of dGNT (Table 1).
In simple DNT, there was a 67% (4/6) agreement with 2 cases
incorrectly diagnosed as complex DNT. In complex DNT,
there was a 75% (6/8) agreement with 2 cases wrongly diag-
nosed as simple DNT (Table 1). In 2 of the cases with lack of
agreement, only small resection samples were available for
histology diagnosis.
TABLE 1. Cases Included in the Study, Clinical Data and Localization of the Lesions, Type of Surgical Resection and Regions of
Tumor Involvement on Pathological Examination
Case
for
Table
Age at
Time of
Surgery
(Years)
Gender Main
Location
of Lesion
on MRI
MRI
Diagnosis
Tissues Resected
as Samples
for Histology
Anatomical
Regions of
Samples with
Tumor
Pathology
Diagnosis
1 39 F L Amyg COMPLEX DNT AMYG, Le, TL, HB,
PHG, PES, CUSA
Amyg, small focus In TL COMPLEX DNT
2a 26 F R parietal SIMPLE DNT Fragments of Le All tissue samples COMPLEX DNT
3 22 F L superior frontal gyrus COMPLEX DNT Fragments of Le All tissue samples COMPLEX DNT
4 20 F R Amyg, HB COMPLEX DNT TL, Le, HB, PES, CUSA ITG, Le, PES COMPLEX DNT
5 35 M R PHG, FG, ITG COMPLEX DNT COMPLEX DNT
6 61 M L medial temporal lesion COMPLEX DNT TL HB, PHG, PES, CUSA ITG, HB, PES COMPLEX DNT
7 42 F R parietal lobe COMPLEX DNT Le, CUSA In samples of Le COMPLEX DNT
8a 28 M R medial temporal lesion SIMPLE DNT TL and Le COMPLEX DNT
9 43 F R MTG dGNT Le and CUSA In samples of Le dGNT
10 17 F R FG dGNT TL, HB, PES, CUSA (2) TL only dGNT
11 31 M L ITG, FG dGNT LE, CUSA In samples of Le dGNT
12 48 F L mesial temporal lesion dGNT TL, HB, Le, PHG, CUSA TL, ITG, HB, Le, PHG dGNT
13 31 F R occipital lobe dGNT Le In samples of Le dGNT
14 16 M L STG dGNT Le and CUSA In samples of Le dGNT
15 26 F R PHG dGNT TL, HB ITG, PHG, HB bdGNT
16 31 M L PHG dGNT TL, HB, PES, Le, CUSA (2) TL, HB, Le bdGNT
17 26 F L PHG dGNT TL, HB, PHG, PES, CUSA TL (ITG) HB, PHG,
CUSA (NOT PES)
bdGNT
18 35 M R STG dGNT TL, HB, PHG, PES, Le, CUSA TL and Le bdGNT
19 18 M L Amyg dGNT TL, HB, PHG, PES, Le, CUSA PHG, FG, Le,
Temporal pole,
HB, PES
cdGNT
20 24 M L MTG dGNT Le and CUSA All tissue samples cdGNT
21 40 M L PHG dGNT TL, HB, PES, Le, CUSA (2) PHG, HIPPO, TL cdGNT
22a 41 M R MTG COMPLEX DNT Le, TL, HB, PHG, PES, CUSA Le and CUSA SIMPLE DNT
23 52 F L frontal rectus gyrus SIMPLE DNT Le In all samples of Le SIMPLE DNT
24 60 F R PHG SIMPLE DNT TL, HB, PHG, PES,
AMYG, CUSA
PHG SIMPLE DNT
25a 31 M L supramarginal gyrus COMPLEX DNT Fragments of Le In all samples of Le SIMPLE DNT
26 26 F R MTG SIMPLE DNT Fragments of Le In all samples of Le SIMPLE DNT
27 27 M L STG SIMPLE DNT Fragments of Le In all samples of Le SIMPLE DNT
The confirmed MRI and pathology diagnosis following review are highlighted in 2 columns. dGNT¼ diffuse glioneuronal tumor, L¼ left, R¼ right, Le¼ samples from main le-
sion/lesionectomy, TL¼ anterior temporal lobectomy (including temporal pole, middle temporal gyrus [MTG], inferior temporal gyrus [ITG] and part of fusiform gyrus [FG], and
superior temporal gyrus [STG]), HB¼ hippocampal body, PHG¼ parahippocampal gyrus, PES¼ pes hippocampus, Amyg¼ amygdala, CUSA¼ cavitron ultrasonic aspiration sam-
ples (either from lesion, amygdala or PHG).
aIndicates cases where there was a mismatch between the pathology and the MRI diagnosis.
bdGNT had a focal ganglioglioma component.
cCases had a diffuse pattern but with some mixed components of conventional DNT.
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Features that more significantly associated with dGNT
was evidence of ill-defined subcortical white matter T2-
w hyperintensity, present in all cases (100%; p< 0.0001;
Fig. 1A) and cortical atrophy found in 92% cases (12/13) with
thinning in the region of tumor infiltration and retraction with
focal prominence of the overlying sulcus forming a CSF filled
space (Fig. 2A, B; Table 2; p< 0.0001). For simple DNTs, sin-
gle well-defined lesions, cystic components, cortical expan-
sion and high signal rim on FLAIR were all more common
than in dGNT (Table 2). Complex DNTs demonstrated more
FIGURE 1. Diffuse GNT. Case 10 (A–D) and Case 19 (E–I). (A) Coronal T2 weighted images showing cortical based lesion of
high signal intensity with subcortical white matter involvement involving the right fusiform gyrus. Note the cortical part of the
lesion that is creating a bridge into the adjacent sulcus (between arrowheads) shown in higher magnification. There is signal
change in the white matter (arrow). (B) Macroscopic image of fixed resection specimen with the slice corresponding to the
lesion seen on MRI; there is focal peri-operative acute hemorrhage into the expanded gyrus. (C) H&E-stained section indicates
the infiltrated gyrus (between arrows) and underlying rarefaction in the white matter correlating with loss of myelin and axons
(arrow). (D) CD34 of the same gyrus at high magnifications shows the diffuse cellular infiltration of the cortex bridging over to
the next gyrus. Case 19: (E) dGNT (which also had areas of mixed complex DNT, not shown here) with lesion in MRI in the
amygdala (arrow). (F) In the temporal lobe resection, diffuse infiltration was confirmed in the inferior-mesial part of the cortex
(arrow). (G) Depletion of neurons seen in this region of diffuse tumors infiltration on NeuN stain (arrow). (H) Diffuse tumor
infiltration in the grey matter from the tissue of the lesion in the amygdala. (I) This same region shows CD34 positivity of tumor
cells. Bars: D¼500 lm; H, I¼300 lm.
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FIGURE 2. Diffuse DNT with cortical and white matter atrophy. Case 11 (A–F) and Case 9 (G–J). (A) Coronal T1 weighted MR
images showing a lesion involving the left fusiform and inferior temporal gyri. (B) The lesion is shown at higher magnification
with cortical atrophy with underlying white matter rarefaction in the region of tumor infiltration as well as apparent overlying
retraction of cortex and a superficial CSF filled space. (C) The fixed resected specimen showing atrophic discolored cortex
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frequent multicystic or “bubbly” appearances (p< 0.001;
Supplementary Data Fig. S1A, B), with 75% also demon-
strating a wedge-shaped lesion (p< 0.001; Supplementary
Data Fig. S1G) or multi-gyral involvement (p< 0.05) com-
pared with other tumors. Half of the complex DNTs also
showed mass effect and bone remodeling. The presence of a
multicystic or “bubbly” appearance was the only significant
radiological difference between simple and complex DNT
(p< 0.01).
In none of the DNT or dGNT in this series was there evi-
dence either on MRI or pathology of a separate or associated
distinct area of FCD in addition to the tumor.
MRI: Pathology Statistical Correlations
Of the MR and pathology features listed in Table 2, 15
significant positive correlations were noted (p< 0.01, Spear-
man’s correlation). A “bubbly” appearance on MRI correlated
FIGURE 2. Continued
(arrowed) and underlying cavitated white matter (star in each image); arrowhead indicates region of normal cortical thickness.
(D) CD34 confirmed extensive cortical tumor infiltration in this region. (E) Panel of NeuN showed, on left laminar cortex in
preserved region (arrowhead in D) compared with middle and right images of tumor infiltration region with laminar cortical
atrophy in region of infiltration. (F) Synaptophysin also highlights laminar neuronal loss in tumor infiltration region (arrow)
imparting an impression of cortical “collapse” rather than expansion. Case 9: (G) Macroscopic section of diffuse GNT with
evidence of cortical atrophy (arrow) and extension into the leptomeningeal tissues forming a mass (asterisk) and with poor
definition between grey and white matter. (H) NeuN on a section from G confirms the thinning and laminar atrophy of the
cortex (arrow) and the lack of a ganglion component in the leptomeninges (asterisk). (I) Higher magnification of the region
shown by arrow in (H) showing laminar neuronal loss and on CD34 in the same region evidence of tumor infiltration. (J) H&E
stain shows focal cavitation and rarefaction of white matter underlying the infiltrated cortex. Bar in J¼400 lm.
TABLE 2. Frequency of Each Feature in the 3 Subtypes of LEAT: Simple, Complex DNT and Diffuse Glioneuronal Tumor (GNT)
Radiological Features Simple
DNT %
(Number
of Cases
Complex
DNT %
(Number
of Cases
Diffuse
GNT %
(Number
Of Cases
p Value # Pathology
Feature
Simple
DNT %
(Number
of Cases
Complex
DNT %
(Number
of Cases
Diffuse
GNT %
(Number
of Cases
p Value #
Expansion of the cortex 50% (3/3) 75% (6/8) 8% (1/13) 0.026* Macroscopic cysts 0% (0/6) 25% (2/8) 8% (1/13) 0.4
Multi-gyral involvement 33% (2/6) 75% (6/8) 38% (5/13) 0.023 Microscopic cysts 33% (2/6) 75% (6/8) 15% (2/13) 0.06
Cystic components 50% (3/6) 88% (7/8) 62% (8/13) 0.03* Distinct nodules 17% (1/6) 100% (8/8) 38% (5/13) 0.005*
Calcification 0% (0/6) 0% (0/8) 46% (6/13) 0.018 Nodules within tumor 17% (1/6) 0% (0/8) 70% (9/13) 0.006
Hemorrhage 0% (0/6) 13% (1/8) 23% (3/13) 0.42 Glioneuronal element 100% (6/6) 100% (8/8) 8% (1/13) 0.000*
Mass effect 33% (2/4) 50% (4/8) 15% (2/13) 0.49 Ventricle extension 17% (1/6) 25% (2/8) 0% (0/13) 0.3
Bone remodeling 0% (0/6) 50% (4/8) 0% (0/13) 0.005 Mucoid matrix 67% (4/6) 100% (8/8) 0% (0/13) 0.000
Single well-defined lesion
without abnormal
signal around it
50% (3/6) 25% (2/8) 0% (0/13) 0.001* Diffuse growth-
predominant pattern
0% (0/6) 0% (0/8) 84% (11/13) 0.000*
Multicystic 0% (0/6) 100% (8/8) 36% (4/11) 0.001 Dysmorphic
neurons absent
100% (6/6) 88% (7/8) 38% (5/13) 0.002
“Bubbly” appearance 33 (2/6) 88% (7/8) 8% (1/13) 0.001* Calcification 0% (0/6) 12% (1/8) 38% (5/13) 0.65
Perilesional/subcortical
white matter signal change
0% (0/6) 13% (1/8) 100% (13) 0.000* Reticulin rich regions 0% (0/6) 0% (0/8) 15% (2/13) 0.3
Wedge shaped lesion 17% (1/6) 75% (6/8) 8% (1/13) 0.001 Pigmentation
(marked or focal)
17% (1/6) 75% (6/8) 77% (10/13) 0.033
Focal high signal
rim on FLAIR
100% 88% (7/8) 62% (8/13) 0.137 White matter changes: 0.017
Marked rarefaction 0% (0/6) 0% (0/8) 30% (4/13)
Subtle myelin loss 0% (0/6) 25% (2/8) 38% (5/13)
Focal cortical atrophy
with prominent
adjacent sulcus
0% (0/6) 12.% (1/8) 92% (12/13) 0.000* Adjacent cortex
layer I hypercellular
0% (0/6) 0% (0/8) 54% (7/13) 0.02
Enhancement 0% (0/6) 25% (2/6) 46% (6/13) 0.055 Dyslamination beyond
tumor infiltration zone
0% (0/6) 0% (0/8) 0% (0/13) 0.15
Close contact with ventricle 33% (2/6) 75% (6/8) 15% (2/13) 0.026 CD34 tumoral expression 0% (0/6) 25% (2/8) 100% (13/13) 0.000
*These features were used as initial defining criteria to classify the cases. There were no statistically significant differences between simple and complex DNT. Significance is
shown for each feature in discriminating between DNT and diffuse GNT subtypes (K–Wallis test); significant values shown in bold as p< 0.01. The presence of rosettes, eosino-
philic granular bodies, Rosenthal fibers, necrosis, or mitotic activity was noted in 0–15% of cases, similar across all tumor groups and therefore not further analyzed.
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with a mucoid matrix pathologically (p< 0.001; Supplemen-
tary Data Fig. S1E) and the presence of a glioneuronal element
(p< 0.0001). The presence of calcification on MRI correlated
with histological evidence of calcium deposits (p< 0.0001).
Subcortical white matter T2w hyper intensity correlated
with a predominant histological diffuse growth pattern
(p< 0.0001), CD34 expression (p< 0.0001; Figs. 1D, I, 2D,
H) and pathological evidence of white matter rarefaction/loss
of myelin (p¼ 0.013; Figs. 1C, 2C, J). Cortical atrophy on
MRI with prominence of the adjacent sulcus correlated with
diffuse histological growth pattern (p< 0.0001) and the pa-
thology showed evidence of cortical neuronal loss, laminar
atrophy, with “collapse” of the cortical ribbon rather than ex-
pansion (Fig. 2).
The MRI features that were significantly more common
in classical DNTs when compared with dGNT were expansion
of the cortex (p< 0.05), the presence of bone remodeling
(p< 0.01), multi-cystic or “bubbly” appearance (p¼ 0.001),
well-defined lesions lacking abnormal surrounding signal
change (p< 0.001) and close contact or “tail-like” extension to-
ward the ventricle (p< 0.05); the latter being a finding in 63%
of complex DNT (Supplementary Data Fig. S1G; Table 2).
In 4 dGNT (cases 15–18), aggregates of atypical gan-
glion cells were also noted on histology as a minor component,
suggestive of focal gangliogliomatous differentiation (Fig. 3)
but no specific features distinguished these cases on MRI. In 3
of the dGNT (cases 19–21), although the diffuse pattern pre-
dominated, the histology also showed focal regions with a
more typical DNT growth pattern or focal glioneuronal ele-
ment. The MRI in these 3 cases also showed features of dGNT
and a minor component more in keeping with DNT, suggest-
ing that some cases may have “hybrid” features (Fig. 4).
MRI: Progressive Changes
Nineteen of the twenty seven cases had been followed
up pre-operatively with a second MRI, the interval period
ranging from 1 to 80 months. None of the simple or complex
cases showed a change in appearance. However, 3 of the dif-
fuse cases showed change in size and appearance; one showed
further atrophy while 2 showed an increase in size.
DISCUSSION
In this study of a series of operated LEATs, we have
shown good agreement between pathology and MRI diagno-
sis. We have identified MRI features that associate with
dGNT to enable its distinction from the typical forms of DNT.
In particular, the presence of peri-lesional signal changes and
cortical atrophy within the tumor zone were MRI features that
were frequent in dGNT and correlated with cortical laminar
neuronal loss and white matter rarefaction in the region of dif-
fuse tumor infiltration. Although some MRI features in typical
DNT may be indicative of its underlying developmental ori-
gin, as the ventricular extension “tail sign,” accompanying
FCD was not confirmed by MRI or pathology in this LEAT
series.
There have been relatively few published studies di-
rectly correlating MRI with pathology in DNT and DNT-like
lesions. Campos et al retrospectively evaluated a series of 61
simple and complex DNT (23). They confirmed a high per-
centage of cases with pseudocysts or smaller cysts with
“septations” (akin to the “bubbly appearance” in our descrip-
tions) that correlated with the specific glioneuronal element.
In the current study, we also confirmed this finding, with all
complex DNT showing multicystic features on MRI and a
strong correlation between “bubbly” appearance on MRI and
a myxoid extracellular matrix of the glioneuronal element on
pathology. In their study, contrast enhancement was present in
21.6% which was comparable to our series (present in 25% of
complex DNT; Table 2). They also noted that the distinction
of simple from complex DNT was often not feasible by MRI
with the only statistically significant discriminating features
being the presence of calcification or hemorrhage in the com-
plex form (23). In the current series, the only feature that dis-
criminated between simple and complex tumors was the pres-
ence of a multicystic and “bubbly” appearance. Furthermore,
the 4 cases with pathology/MRI disagreement in this study
were between the simple and complex subtypes. Although this
may be partly explained by small tissue sample size in 2 cases,
it calls to question that simple and complex may represent a
spectrum of the same tumor and questions the rationale to dis-
criminate these in the WHO classification of CNS tumors (5).
We showed 100% agreement between the MRI and his-
tology diagnosis of dGNT, supporting its distinction from con-
ventional DNT within the LEAT tumor group. The only previ-
ous MRI/pathology correlative study of diffuse LEAT tumor
types noted their poor-delineation on MRI with grey-white
matter blurring, subcortical signal changes and frequent loca-
tion in mesial temporal lobe (15); this MRI appearance was
termed “dysplastic-like” when compared with the cystic/nodu-
lar appearances of typical DNT. Despite the frequent recogni-
tion of “dGNT” types in epilepsy surgical series, these tumors
continue to be controversial, masquerading under a range of
diagnostic labels over the years from “diffuse/nonspecific
DNT” to the more recent “PLNTY” (7, 11, 14, 21). Although
lagging behind recent progress in conventional gliomas (2),
future advances in the molecular genetic characterization of
LEATs (13, 14, 24, 25), including DNA methylation profiling,
will undoubtedly advance the much-needed revisions in the
nomenclature, including the accommodation and integration
of dGNT into the WHO classification (1, 12). In this study, an
in-depth molecular analysis was not carried out to further clas-
sify these tumors which is a limitation. Recent studies high-
light tentative biological linkage of dGNT with DNT through
genetic abnormalities in FGFR1 (13, 24) and some tumors (in-
cluding cases in the present study) showing hybrid histological
features of dGNT and DNT. There is more compelling evi-
dence, however, grouping dGNT with ganglioglioma through
the shared and predominant expression patterns of CD34, ob-
servation of foci of atypical ganglion cells (including cases in
the present study) more frequent BRAF V600E gene mutations
than DNT and methylation cluster analysis (14, 25, 26). Future
molecular studies on large series of LEATs will likely confirm
the molecular classification of dGNT as well as the nature of
tumors with hybrid features of more than one WHO tumor
type (27–32).
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FIGURE 3. Diffuse GNT with focal gangliogliomatous component. Case 16 (A–H) and Case 17 (J–O). (A) Coronal T1, (B) FLAIR,
and (C) T2 weighted MR images showing apparent cortical atrophy underlying white matter signal abnormality with multigyral
involvement by the tumor. (D) The main temporal lobe resection specimen included the middle temporal gyrus the inferior
temporal gyrus (ITG) and part of the fusiform gyrus (FG). The ITG (shown in square) was infiltrated by a diffuse tumor: (E, F) The
same region at higher magnifications shows infiltration of the cortex, reduced neuronal density being “displaced” by NeuN-
negative oligodendrocyte-like cells which distort the neuronal morphology. (G) Higher magnification of this same region
showing clusters of CD34-positive tumor cells in the cortex and cortical layer I; these are shown in H and in high magnification in
I. A sample from the main lesion in the amygdala contained a small focus with atypical gangliod cells. Case 17: (J) Coronal T1,
(K) T2, and (L) FLAIR weighted MR images showing left temporal lobe lesion centered on the parahippocampal gyrus with
perilesional signal abnormality and cortical atrophy in the adjacent temporal lobe. (M) The main temporal lobe resection
including the inferior temporal gyrus (ITG) showed microscopic evidence of diffuse infiltration as shown on CD34 stain in (N);
note the widespread labeling of CD34-positive cells along subpial border in layer I (arrow). In deeper sections, a focus of atypical
ganglion cells was noted in the superior aspect at the inferior-medial resection margin (arrowhead); (O) this correlated with
calbindin positivity and synaptophysin-positive atypical gangliod cells are shown in this region in the inset. Bars: F¼250 lm; G,
H, N (inset)¼60 lm.
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In the current study, the most frequent MRI features of
dGNT were peri-lesional T2 signal change and cortical atro-
phy within the tumor zone; these correlated with degenerative
features on pathology, including cortical laminar atrophy and
white matter rarefaction with axonal and myelin loss.
These superimposed “atrophic” features could be an effect of
the seizures themselves or attest to the slow growth rate and
long-standing nature of the dGNT and is in keeping with the
documented accumulation of degenerative changes reported,
including TDP43, tau and p62 (6, 33). We failed, however, to
FIGURE 4. Diffuse GNT with mixed features of DNT. Case 21: A lesion centered in the left parahippocampal gyrus. (A) Coronal
T1, (B) T2, and (C) FLAIR MR images showing the lesion involving the left parahippocampal gyrus with a triangular wedge-
shaped appearance and a multiple cystic appearance. The wedge-shaped lesion points toward the temporal horn of the left
lateral ventricle and the appearance of the tumor in this region resembles the complex subtype of DNT. (D) Tissue from the
main lesion showed glioneuronal element with floating neurons characteristic of DNT on NeuN stain. (E) In the main temporal
lobe specimen, which included the fusiform gyrus (FG) and part of the parahippocampal gyrus (PHG), there was diffuse pattern
of tumor infiltration which was the dominant overall growth pattern as shown on NeuN stain in (F). The region shown in the
square is shown at higher magnification in (G) and rotated 180. (H) The infiltrating cells showed patchy CD34 labeling. (I)
Coronal T1, (J) T2, and (K) FLAIR corresponding to the level shown in (E) confirmed an ill-defined white matter signal
abnormality with cortical atrophy; this part of the lesion resembled diffuse GNT. Bars: D¼100 lm; G, H¼175 lm, based on
original magnifications.
J Neuropathol Exp Neurol • Volume 76, Number 12, December 2017 Pathology: MRI Correlations in Low-Grade Epilepsy Tumors
1031
Downloaded from https://academic.oup.com/jnen/article-abstract/76/12/1023/4484337
by University College London user
on 22 March 2018
confirm co-existing FCD by MRI or histology. FCD associ-
ated with LEAT was recently assigned to FCD type IIIb in the
ILAE classification (16). The incidence of FCDIIIb, however,
varies greatly between series; for example, in the published
MRI/pathology correlative studies of DNT, co-existing FCD
was reported in 0/61 cases (23) compared with 25/78 (32%)
(15). This is likely due to a lack of clear criteria for FCDIIIb
(1, 16, 18, 34) and distinction from tumor infiltrative regions
(22), and it remains a contentious but important area, includ-
ing contribution to epileptogenicity (34). However, the strik-
ing “wedge” or funnel shape appearance of DNT noted on
MRI (23, 35) was present in 75% of our complex DNT and as-
sociation or contact with the ventricle in 63%, reminiscent of
the transmantle/“tail sign” of FCD IIB. A developmental ori-
gin of DNT from the peri-ventricular region and germinal ma-
trix has been previously proposed (36).
The advances in the molecular characterization of
LEATS, as well as providing diagnostic and prognostic bio-
markers, will undoubtedly herald a future of individualized
treatment plans including tailored surgery (37–40). The accu-
rate recognition of dGNT on pre-operative MRI and their dis-
tinction from other LEATs as well as the more common dif-
fuse low-grade gliomas in adulthood will remain an integral
component for appropriate surgical planning. This has particu-
lar relevance in dGNT in terms of defining the boundaries of
the lesion compared with the epileptogenic zone (9, 15, 41).
This study is limited in that it did not carry out full molecular
characterization of tumors, correlate MRI lesion with EEG for
delineation of epileptogenic zone or compare dGNT with con-
ventional low-grade gliomas or typical gangliogliomas. These
would all be important to address in future studies of dGNT to
further refine diagnostic criteria and similarities and differen-
ces between tumor types. Nevertheless, this study has
highlighted the potential of conventional MRI to distinguish
dGNT for the future pre-operative identification of this com-
mon LEAT subtype. The diagnostic validity of these features
will have to be assessed in a prospective study.
REFERENCES
1. Thom M, Blumcke I, Aronica E. Long-term epilepsy-associated tumors.
Brain Pathol 2012;22:350–79
2. Blumcke I, Aronica E, Becker A, et al. Low-grade epilepsy-associated
neuroepithelial tumours – the 2016 WHO classification. Nat Rev Neurol
2016;12:732–40
3. Nguyen HS, Doan N, Gelsomino M, et al. Dysembryoplastic neuroecto-
dermal tumor: an analysis from the surveillance, epidemiology, and end
results program, 2004–2013. World Neurosurg 2017;103:380–5
4. Bonney PA, Glenn CA, Ebeling PA, et al. Seizure freedom rates and
prognostic indicators after resection of gangliogliomas: a review. World
Neurosurg 2015;84:1988–96
5. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification
of Tumours of the Central Nervous System. WHO/IARC Classification of
Tumours, revised 4th Edition. Volume 1.
6. Thom M, Toma A, An S, et al. One hundred and one dysembryoplastic
neuroepithelial tumors: an adult epilepsy series with immunohistochemi-
cal, molecular genetic, and clinical correlations and a review of the litera-
ture. J Neuropathol Exp Neurol 2011;70:859–78
7. Bodi I, Selway R, Bannister P, et al. Diffuse form of dysembryoplastic
neuroepithelial tumour: the histological and immunohistochemical fea-
tures of a distinct entity showing transition to dysembryoplastic neuroe-
pithelial tumour and ganglioglioma. Neuropathol Appl Neurobiol 2012;
38:411–25
8. Burneo JG, Tellez-Zenteno J, Steven DA, et al. Adult-onset epilepsy as-
sociated with dysembryoplastic neuroepithelial tumors. Seizure 2008;17:
498–504
9. Chassoux F, Daumas-Duport C. Dysembryoplastic neuroepithelial
tumors: where are we now? Epilepsia 2013;54(Suppl. 9):129–34
10. Daumas-Duport C, Varlet P, Bacha S, et al. Dysembryoplastic neuroepi-
thelial tumors: nonspecific histological forms – a study of 40 cases. J
Neurooncol 1999;41:267–80
11. Honavar M, Janota I, Polkey CE. Histological heterogeneity of dysem-
bryoplastic neuroepithelial tumour: identification and differential diag-
nosis in a series of 74 cases. Histopathology 1999;34:342–56
12. Blumcke I, Aronica E, Urbach H, et al. A neuropathology-based ap-
proach to epilepsy surgery in brain tumors and proposal for a new termi-
nology use for long-term epilepsy-associated brain tumors. Acta
Neuropathol 2014;128:39–54
13. Qaddoumi I, Orisme W, Wen J, et al. Genetic alterations in uncommon
low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations
occur at high frequency and align with morphology. Acta Neuropathol
2016;131:833–45
14. Huse JT, Snuderl M, Jones DT, et al. Polymorphous low-grade neuroepi-
thelial tumor of the young (PLNTY): an epileptogenic neoplasm with
oligodendroglioma-like components, aberrant CD34 expression, and ge-
netic alterations involving the MAP kinase pathway. Acta Neuropathol
2017;133:417–29
15. Chassoux F, Rodrigo S, Mellerio C, et al. Dysembryoplastic neuroepithe-
lial tumors: an MRI-based scheme for epilepsy surgery. Neurology 2012;
79:1699–707
16. Blumcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of
focal cortical dysplasias: a consensus classification proposed by an ad
hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia
2011;52:158–74
17. Cavanagh JB. On certain small tumours encountered in the temporal
lobe. Brain 1958;81:389–405
18. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, et al. Dysembryo-
plastic neuroepithelial tumor: a surgically curable tumor of young
patients with intractable partial seizures. Report of thirty-nine cases.
Neurosurgery 1988;23:545–56
19. Lee MC, Kang JY, Seol MB, et al. Clinical features and epileptogenesis
of dysembryoplastic neuroepithelial tumor. Childs Nerv Syst 2006;22:
1611–8
20. Nolan MA, Sakuta R, Chuang N, et al. Dysembryoplastic neuroepithelial
tumors in childhood: long-term outcome and prognostic features. Neurol-
ogy 2004;62:2270–6
21. Pasquier B, Peoc HM, Fabre-Bocquentin B, et al. Surgical pathology of
drug-resistant partial epilepsy. A 10-year-experience with a series of 327
consecutive resections. Epileptic Disord 2002;4:99–119
22. Palmini A, Paglioli E, Silva VD. Developmental tumors and adjacent
cortical dysplasia: single or dual pathology? Epilepsia 2013;54(Suppl.
9):18–24
23. Campos AR, Clusmann H, von Lehe M, et al. Simple and complex dys-
embryoplastic neuroepithelial tumors (DNT) variants: clinical profile,
MRI, and histopathology. Neuroradiology 2009;51:433–43
24. Rivera B, Gayden T, Carrot-Zhang J, et al. Germline and somatic FGFR1
abnormalities in dysembryoplastic neuroepithelial tumors. Acta Neuro-
pathol 2016;131:847–63
25. Gierke M, Sperveslage J, Schwab D, et al. Analysis of IDH1-R132 muta-
tion, BRAF V600 mutation and KIAA1549-BRAF fusion transcript sta-
tus in central nervous system tumors supports pediatric tumor
classification. J Cancer Res Clin Oncol 2016;142:89–100
26. Prabowo AS, Iyer AM, Veersema TJ, et al. BRAF V600E mutation is as-
sociated with mTOR signaling activation in glioneuronal tumors. Brain
Pathol 2014;24:52–66
27. Matyja E, Grajkowska W, Kunert P, et al. A peculiar histopathological
form of dysembryoplastic neuroepithelial tumor with separated pilocytic
astrocytoma and rosette-forming glioneuronal tumor components. Neu-
ropathology 2014;34:491–8
28. Eye PG, Davidson L, Malafronte PJ, et al. PIK3CA mutation in a mixed
dysembryoplastic neuroepithelial tumor and rosette forming glioneuronal
tumor, a case report and literature review. J Neurol Sci 2017;373:280–4
29. Perry A, Giannini C, Scheithauer BW, et al. Composite pleomorphic xan-
thoastrocytoma and ganglioglioma: report of four cases and review of the
literature. Am J Surg Pathol 1997;21:763–71
Al-Hajri et al J Neuropathol Exp Neurol • Volume 76, Number 12, December 2017
1032
Downloaded from https://academic.oup.com/jnen/article-abstract/76/12/1023/4484337
by University College London user
on 22 March 2018
30. Prayson RA. Composite ganglioglioma and dysembryoplastic neuroepi-
thelial tumor. Arch Pathol Lab Med 1999;123:247–50
31. Prayson RA, Napekoski KM. Composite ganglioglioma/dysembryoplas-
tic neuroepithelial tumor: a clinicopathologic study of 8 cases. Hum
Pathol 2012;43:1113–8
32. Yeh DJ, Hessler RB, Stevens EA, et al. Composite pleomorphic
xanthoastrocytoma–ganglioglioma presenting as a suprasellar mass: case
report. Neurosurgery 2003;52:1465–8. discussion 8–9
33. Prabowo AS, Iyer AM, Veersema TJ, et al. Expression of neurodegenera-
tive disease-related proteins and caspase-3 in glioneuronal tumours. Neu-
ropathol Appl Neurobiol 2015;41:e1–e15
34. Giulioni M, Martinoni M, Marucci G. Observations on epilepsy associ-
ated with low-grade tumors and focal cortical dysplasias. Childs Nerv
Syst 2015;31:507–9
35. Zhang JG, Hu WZ, Zhao RJ, et al. Dysembryoplastic neuroepithelial tu-
mor: a clinical, neuroradiological, and pathological study of 15 cases. J
Child Neurol 2014;29:1441–7
36. Kawataki T, Sato E, Kato T, et al. A cortical dysembryoplastic neuroepi-
thelial tumor initially occurring in the periventricular white matter. J
Neurosurg Ped 2010;6:600–3
37. Brat DJ, Verhaak RG, Aldape KD, et al. Comprehensive, integrative ge-
nomic analysis of diffuse lower-grade gliomas. N Engl J Med 2015;372:
2481–98
38. Garcia MA, Solomon DA, Haas-Kogan DA. Exploiting molecular biol-
ogy for diagnosis and targeted management of pediatric low-grade glio-
mas. Future Oncol 2016;12:1493–506
39. Khatua S, Wang J, Rajaram V. Review of low-grade gliomas in children
– evolving molecular era and therapeutic insights. Childs Nerv Syst
2015;31:643–52
40. Nageswara Rao AA, Packer RJ. Advances in the management of low-
grade gliomas. Curr Oncol Rep 2014;16:398
41. Chassoux F, Landre E, Mellerio C, et al. Dysembryoplastic neuroepithe-
lial tumors: epileptogenicity related to histologic subtypes. Clin Neuro-
physiol 2013;124:1068–78
J Neuropathol Exp Neurol • Volume 76, Number 12, December 2017 Pathology: MRI Correlations in Low-Grade Epilepsy Tumors
1033
Downloaded from https://academic.oup.com/jnen/article-abstract/76/12/1023/4484337
by University College London user
on 22 March 2018
